By demonstrating that the premalignant niche is actively remodelled to favor mutant haematopoiesis, this study identifies MSC senescence as a relevant mechanism regulating CH evolution and a potential target for early disease intervention.
Abstract
Clonal haematopoiesis (CH) is characterized by the age-associated expansion of mutant haematopoietic clones. How these clones expand, interact with the niche, and maintain a competitive advantage remains poorly understood. In a recent study published in Nature Cell Biology, Mistry and colleagues uncover that senescence in the bone marrow stromal microenvironment is a key contributor to the clonal growth of haematopoietic stem and progenitor cells (HSPCs) carrying CH mutations. Using mouse models and primary human samples, they show that mutant haematopoietic cells induce MSC senescence through contact-independent, cytokine-mediated signalling involving TNF-α, IL-6 and STAT3. Senescent MSCs preferentially support mutant haematopoietic stem and progenitor cells (HSPCs) over wild-type cells. Moreover, genetic or pharmacological depletion of senescent non-haematopoietic cells reduces CH burden and delays progression towards myeloid neoplasia in mice. By demonstrating that the premalignant niche is actively remodelled to favor mutant haematopoiesis, this study identifies MSC senescence as a relevant mechanism regulating CH evolution and a potential target for early disease intervention.
Recent advances in understanding dysregulated HSC control in the early stages of myeloid neoplasia are summarized, with particular emphasis on aging, inflammation, immune interactions, and crosstalk with the bone marrow niche.
Masayuki Yamashita· [Rinsho ketsueki] The Japane...· 0 citations
Interactions of hematopoietic stem cells (HSCs) with the bone marrow microenvironment are critical to regulate stem cell function in homeostasis, emergency hematopoiesis and ageing. The dynamic behavior of endogenous HSCs in their niches has been challenging to study due to the complexity of markers required to define...
Marine A. Secchi, Cera Mai, Qi Liu et al.· Blood· 0 citations
Clonal hematopoiesis of indeterminate potential (CHIP) raises cardiovascular risk, yet the size of a clone in blood does not by itself explain how that clone contributes to disease. We argue that selection acts not once but at three dissociable checkpoints: competition among hematopoietic stem cells, myeloid lineage...
K. Ueno, Y. Nakayama· Frontiers in Cardiovascular...· 0 citations
Bone marrow macrophages (BMMs) coordinate skeletal remodelling, haematopoietic niche function, immune surveillance, and tissue repair. Whether a persistent senescent state in BMMs is a causal driver of skeletal ageing, however, remains unresolved. The central challenge is both definitional and causal: macrophages may b...
Zhe Li, Ying Li, Lei Sui et al.· Ageing Research Reviews· 0 citations
Hematopoietic stem cells (HSCs) maintain their function through interactions with niche cells in the bone marrow. We previously demonstrated that protection of telomeres 1a (Pot1a), a shelterin component, maintains HSCs and neuron-glial antigen 2-expressing (NG2+) mesenchymal stem cells (MSCs) by suppressing DNA damage...
Yuki Esaki, K. Hosokawa, Hisayuki Yao et al.· Cell Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.